Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

29,434 total articles

BMO Flags Bombardier Sell-Off as Overdone, Calls It a Buy

BMO Flags Bombardier Sell-Off as Overdone, Calls It a Buy

BMO Capital Markets maintained an Outperform rating on Bombardier and raised its price target to C$375, arguing that recent share declines driven by tariff and supply-chain worries have been exaggerated. The bank says demand and order flow remain healthy, the company’s purchase of MHI Canada Aerospace should lower production risk, and 2026 free cas…

Citigroup Pushes Back Expected Fed Rate Cut to Mid-2027

Citigroup Pushes Back Expected Fed Rate Cut to Mid-2027

Citigroup has revised its forecast for the Federal Reserve’s next interest-rate reduction, moving the first cut to June 2027 and projecting three 25-basis-point cuts in June, September and December of that year. The change follows an August jobs report that showed stronger employment and higher labor force participation, prompting futures markets t…

Warsaw benchmark rises as banking, media and construction stocks drive gains

Warsaw benchmark rises as banking, media and construction stocks drive gains

Poland's equity market closed higher on Friday, led by advances in the Banking, Media and Construction sectors. The WIG30 index rose 1.29% at the Warsaw close, supported by notable gains in Jastrzebska Spotka Weglowa SA, Budimex SA and Erste Bank Polska SA. Market breadth favoured advancers, while crude oil and gold prices retreated and the zloty w…

Johnson & Johnson Climbs to Fresh Highs as Valuation Debate Heats Up

Johnson & Johnson Climbs to Fresh Highs as Valuation Debate Heats Up

Johnson & Johnson has surged to $275.66 after delivering a 59.3% total return over the past year, powered by FDA clearances, new drug approvals and revenue growth. Street targets are split, with a bull case at $320 and InvestingPro’s Fair Value model implying nearly 10% downside. The stock’s forward multiples reflect hopes for robust oncology-led e…

Portugal Seeks Enhanced Bids from Air France-KLM and Lufthansa for TAP Stake

Portugal Seeks Enhanced Bids from Air France-KLM and Lufthansa for TAP Stake

Portugal has asked Air France-KLM and Lufthansa to improve their binding offers for a 44.9% minority stake in national carrier TAP, initiating a final round of negotiations after state evaluators judged the proposals broadly similar. The process follows the government’s revival of TAP’s privatization in July 2025 and preserves a 5% employee stake.

European regulator opens safety review of injectable iron therapies

European regulator opens safety review of injectable iron therapies

The European Medicines Agency's safety committee has launched a review of all injectable iron-containing medicines following reports of low blood phosphate levels and bone softening associated with treatments containing ferric carboxymaltose and other injectable iron products. The committee will assess whether the reported risks change the medicine…